Sorry, you need to enable JavaScript to visit this website.

    Pfizer's Waxman to Leave

    Remains Outside Counsel Through Transition Period

    (BUSINESS WIRE)--Pfizer said today that Senior Vice President and General Counsel Allen Waxman is leaving the company for personal reasons. Mr. Waxman will remain outside counsel to Pfizer through a transition period.

    Pfizer said David Reid, currently Senior Vice President and Managing Director, will assume Mr. Waxmans responsibilities on an interim basis while the company conducts a search for a permanent successor.

    Allen and his team have been strong advocates for Pfizer, securing a number of important legal decisions that are significant for our business and our future, said Jeff Kindler, Chairman and Chief Executive Officer. Allen has provided valuable counsel not only on legal matters but on our overall business strategy and the issues facing Pfizer in its operating environment. He has made many contributions to our company. We thank him for those contributions and wish him well in his future endeavors.

    Pfizer Inc
    Media Relations:
    Ray Kerins, 212-733-9203
    Investor Development:
    Suzanne Harnett, 212-733-8009



    Sign up for the latest Pfizer Wire news alerts

    Receive real-time updates on Pfizer’s news delivered directly to your inbox.

    Our Pipeline: Potential Breakthroughs in the Making

    We're elevating our breakthroughs in a bold new way. Check out our new visualized product pipeline.

    Corporate Fact Sheet

    For more than 170 years, Pfizer has worked to make a difference for all who rely on us.

    Media Asset Library

    Click here to view our media asset library.

    Pfizer Logo

    Our logo is shorthand for everything Pfizer represents: an image that is instantly identifiable to our colleagues, patients, the external scientific community, and the public.

    Executive Leadership

    Meet the executive leadership team, our senior-most leadership and decision-making management body who focus on major financial, strategic, and operational decisions for the entire company.

    Stay up to date on the latest news and alerts through the Pfizer Wire

    Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox. 

     

    Sign Up Now